The two SREBPs resemble each other in sequence mutant Chinese hamster ovary cells are auxotrophic throughout their length. They share the three-segment for cholesterol because they fail to carry out the secstructure and the susceptibility to sterol-regulated proond cleavage; the NH 2 -segment remains membraneteolysis. Although they can form heterodimers, such forbound and transcription is not activated. 
that are activated when cells undergo programmed cell amino acids that projects into the lumen of the endoplasdeath (Wang et al., 1995 (Wang et al., , 1996 Pai et al., 1996) . This mic reticulum (ER) and nuclear envelope. The carboxy apoptosis-induced cleavage occurs at a site in the (COOH)-terminal segment, about 500 amino acids in SREBP molecule that is distinct from the sterol-regulength, also projects into the cytosol, where it plays a lated cleavage site. The functional significance of this role in sterol-mediated regulation of SREBP cleavage apoptosis-induced cleavage is unknown. (Hua et al., 1995 (Hua et al., , 1996 .
Chin and Chang (1981) originally described a line of When cells are depleted of cholesterol, one or more mutant CHO cells that is unable to induce transcription proteases clip each SREBP near the first transmemof the genes encoding cholesterol biosynthetic enzymes brane domain, releasing the NH2-terminal segment or the LDL receptor in response to sterol deprivation. Hua et al., 1995) . This released segMore recently, two similar mutant cell lines have been ment enters the nucleus and activates transcription by developed. These are designated M19 cells (Hasan et binding to a 10 bp sterol regulatory element (SRE-1) al., 1994) and SRD-6B cells (Evans and Metherall, 1993) . in the promoters of the genes encoding 3-hydroxy-3-They all require exogenous cholesterol for growth. The methylglutaryl CoA synthase, which is a regulated endefect in the M19 cells was corrected by transfection of human genomic DNA (Hasan et al., 1994). The zyme in the cholesterol biosynthetic pathway, and the transfected cells regained the ability to induce transcription of the cholesterol biosynthetic enzymes as well as the LDL receptor. These findings raised the possibility that the M19 cells (and probably the SRD-6B cells) have some defect in the cleavage or activation of SREBPs. Up to now, however, the status of the SREBPs in these cells has not been determined.
Our laboratory is actively attempting to identify the sterol-regulated protease or proteases that clip the SREBPs, to determine the site of clipping, and to determine the mechanism by which sterols inhibit this process. In a recent technical advance, we developed a transfection system by which to monitor sterol-regulated proteolysis of epitope-tagged SREBPs (Hua et al., 1996) . Human 293 cells are transfected with cDNAs encoding tagged SREBP-1 or SREBP-2 under control of the relatively weak herpes simplex virus (HSV) thymidine kinase (TK) promoter. This produces an amount of tagged SREBPs that is roughly equivalent to the amount of endogenous SREBP. Under these conditions, cleavage of the tagged SREBPs takes place in the normal fashion and is down-regulated by sterols in parallel with endogenous SREBPs (Hua et al., 1996) . We used the above transfection system to demonstrate that two elements of the SREBPs are required for maximal proteolysis, one on either side of the first transmembrane domain (Hua et al., 1996) . One element is an arginine residue that is near the middle of the lumenal loop. Replacement of this arginine with an ala- nine and a second cleavage, dependent on DRSR, that releases the NH2-terminal segment from the membrane. membranes of the ER and nuclear envelope (Figure 1) . Unexpectedly, the second cleavage occurs not at the The first cleavage, which is regulated by sterols, ocsite of the DRSR, but rather at a site within the first curred at or near the arginine in the lumenal loop that transmembrane segment. In two mutant lines of choleshad been previously shown to be required for cleavage terol auxotrophs (SRD-6B and M19 cells), both SREBP-1 ( Figure 1A ). The NH 2 -terminal segment produced by this and -2 failed to be released from the membrane. This cleavage, designated intermediate (I form), remains failure was not due to a defect in the initial sterol-regumembrane-bound ( Figure 1B) . The second cleavage oclated proteolytic step but rather was caused by a lack curs within the transmembrane domain, liberating the of activity of the second protease that cleaved within mature NH2-terminal fragment (M form) from the memthe transmembrane segment. brane ( Figure 1C ). This cleavage occurs only after the first cleavage has taken place. In the remaining figures, we provide evidence to support this model. (Figure 8, lanes 2, 3, 11 , and 519/DRSR→AS). As expected, the full-length protein was cleaved to generate a mature nuclear form, and this 12). The SRD-6B and M19 cells failed to show the mature nuclear form of SREBP-1 or -2 under any condition (Figwas abolished by sterols (Figure 7, lower panel, lanes  3 and 4) . The DRSR→AS mutant gave rise to an intermeure 8, lower panel, lanes 4-9 and 13-18). These mutant cells did, however, accumulate a proteolyzed memdiate membrane-bound form in a sterol-regulated fashion (Figure 7, upper panel, lanes 7 and 8) . The Stop brane-bound form that was present in the absence of sterols with or without compactin and was suppressed 519 mutant gave rise to a mature nuclear form, but the amount was not decreased in the presence of sterols completely when sterols were added. This form is designated I in Figure 8 (upper panel, lanes 4-9 and 13-18 ). (Figure 7, lower panel, lanes 5 and 6) . To make certain that the mature nuclear form was generated from the The size of the endogenous membrane-bound intermediate form in the SRD-6B and M19 cells is similar to that Stop 519 mutant as a result of cleavage at the DRSR of the transfected epitope-tagged intermediate form that accumulated in 293 cells when the DRSR sequence was mutated to AS (see Figure 2) . The intermediate in the SRD-6B and M19 cells also resisted solubilization with high salt or Na2CO3 (data not shown). We interpret these findings to indicate that the SRD-6B and M19 cells carry out the first sterol-regulated cleavage of the SREBPs but that they lack the ability to carry out the second DRSR dependent cleavage.
Results

Discussion
The current results reveal a complex mechanism for the proteolytic release of SREBP-2 from the membranes of the ER and nuclear envelope. The first event is a cleavage at or near Arg-519 in the lumenal loop that generates an intermediate form of SREBP-2 that remains membrane-bound. This cleavage is accelerated in steroldepleted cells, and it is reduced when sterols accumulate. The second cleavage, which appears to occur within the first transmembrane domain, requires the D 478 RSR sequence immediately adjacent to this domain. The second cleavage is not regulated directly by sterols, but it occurs only after the first cleavage has taken place. After the second cleavage, the NH 2 -terminal mature form of SREBP-2 leaves the membrane and translocates to the nucleus (Figure 1) .
The two-cleavage mechanism explains our previous finding that release of the mature form of SREBP-2 re- On day 0, the indicated cells were set up as described in Experimental Procedures. On day 2, the medium was changed to medium A containing 5% fetal calf lipoprotein-deficient serum and 50 M sodium mevalonate supplemented with either 50 M compactin (plus compactin) or 1 g/ml 25-hydroxycholesterol plus 10 g/ml cholesterol (plus sterols), as indicated. On day 3, 4 hr before the harvest, all cells received 25 g/ml N-acetyl-leucineleucine-norleucinal. The cells were harvested, fractionated as described in Experimental Procedures, and aliquots (50 g protein) of the membrane and nuclear extract fractions were subjected to SDS-PAGE. Immunoblot analysis was carried out with 15 g/ml IgG-2A4 for SREBP-1 (A) or 7.5 g/ml IgG-7D4 antibody for SREBP-2 (B). In (A), filters for both fractions were exposed to film for 60 s; in (B), filters for the membrane and nuclear extracts fractions were exposed to film for 2 min and 15 s, respectively. P were able to show that it was generated only in sterolApparently, the sole role of sterols is to regulate the first cleavage. The Stop 519 mutant lacks the second depleted cells.
The finding that the mutant SRD-6B and M19 cells are transmembrane region, and we do not know whether it was inserted fully into the membrane or merely adherent defective only in the second cleavage reaction suggests, but does not prove, that the two cleavages are carried to the surface. Nevertheless, it was accessible to the DRSR dependent protease. We also observed cleavage out by different enzymes. We cannot rule out the possibility that a single enzyme carries out both reactions of the truncated forms that stopped at positions 503 and 511, which also may not have been inserted inteand that the mutation in these cells selectively abolishes the ability of the protein to carry out the second grally into the membrane (Figure 6 ). All of these findings suggest that the second protease may be associated cleavage.
Based on the size of the intermediate form, we estiwith the cytoplasmic surface of the membrane. All of the transfection experiments in this paper were mate that the first cleavage reaction occurs at or very near the required arginine (Arg-519), which is approxiperformed with SREBP-2. We do not yet know whether SREBP-1 behaves in a similar fashion. The finding that mately in the middle of the 31 residue lumenal loop (Figures 1 and 6) . Confirmation of this hypothesis will the intermediate form of SREBP-1, as well as that of SREBP-2, accumulates in the membrane of the mutant require isolation of the COOH-terminal product created by this cleavage and determination of its NH2-terminal SRD-6B and M19 cells (Figure 8 ) suggests that SREBP-1 also undergoes two sequential cleavages. Indeed, sequence.
The experiment of Figure 6 , performed with size stan-SREBP-1 possesses an arginine at a position equivalent to Arg-519 of SREBP-2, and it also shares the DRSR dards, suggests that the second cleavage occurs between residues 482 and 502, which places it within the sequence, both of which are required for its release from membranes (Hua et al., 1996) . However, experiments in first transmembrane domain. It is possible that the protease is embedded in the membrane with its active site livers of intact animals suggest that SREBP-1 may be processed to a mature form under conditions in which contained within a hydrophilic membrane channel. Alternatively, the protease may be located on the surface of the processing of SREBP-2 does not occur (Sheng et al., 1995) . Thus, a firm conclusion as to the mechanism the membrane, and it might have some mechanism for extracting the hydrophobic segment from the memof processing of SREBP-1 awaits detailed studies with this protein. brane prior to cleavage. The latter mechanism is favored by the requirement for the DRSR sequence, which might be a binding site for such a protease on the external in some ways the cleavage of the amyloid precursor protein (APP) that generates the amyloid ␤ protein in
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Alzheimer's disease (Selkoe, 1994) . This cleavage also The antibodies were visualized with peroxidase-conjugated affinityviously (Hua et al., 1995 (Hua et al., , 1996 . Medium for inducing conditions purified donkey anti-mouse IgG, using the SuperSignal TM CL-HRP included 10% (v/v) newborn calf lipoprotein-deficient serum, 50 M Substrate System according to the instructions of the manufacturer. compactin, 50 M sodium mevalonate, and 0.2% (v/v) ethanol. MeGels were calibrated with prestained molecular mass markers (New dium for suppressing conditions included the same medium plus a England Biolabs). The blots were exposed to Dupont-NEF 496 film mixture of 1-3 g/ml 25-hydroxycholesterol plus 10 g/ml cholesat room temperature for the time indicated in the legends. terol. Cell fractionation was carried out as described previously (Hua et al., 1995 (Hua et al., , 1996 
